GlaxoSmithKline Pakistan Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was PKR 35,090.112 million compared to PKR 36,581.749 million a year ago. Operating income was PKR 4,986.793 million compared to PKR 4,889.907 million a year ago. Net income was PKR 3,375.240 million compared to PKR 3,041.123 million a year ago. Basic earnings per share from continuing operations was PKR 10.6 compared to PKR 9.55 a year ago.